As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

As Ozempic and other GLP-1 drugs explode in popularity ... with far less stringent oversight than their name brand inspiration. Meanwhile, as influencers on social media platforms like TikTok ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication ...

The millennial-targeted telehealth company Hims & Hers (HIMS) is spending big bucks on its first ever Super Bowl commercial ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer refused to cover Zepbound, the ...